Stage IIB Esophageal Adenocarcinoma
2 clinical trials · Condition
◉ Watch Stage IIB Esophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy (NCT02392377) | Case Comprehensive Cancer Center | 2015-02-01 |
| Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery (NCT02234180) | Academic and Community Cancer Research United | 2014-09-01 |
Track Stage IIB Esophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.